Labcorp ROI - Return on Investment 2010-2025 | LH

Labcorp return on investment for the quarter ending March 31, 2025 was 5.6.

  • Labcorp average return on investment for 2024 was 4.26, a 13.59% increase from 2023.
  • Labcorp average return on investment for 2023 was 4.93, a 56.1% decline from 2022.
  • Labcorp average return on investment for 2022 was 11.23, a 36.84% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Labcorp ROI - Return on Investment 2010-2025 | LH

  • Labcorp average return on investment for 2024 was 4.26, a 13.59% increase from 2023.
  • Labcorp average return on investment for 2023 was 4.93, a 56.1% decline from 2022.
  • Labcorp average return on investment for 2022 was 11.23, a 36.84% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$87.4B
Becton Dickinson (BDX)$57.1B
Cardinal Health (CAH)$32.5B
Straumann Holding AG (SAUHY)$18.7B
Cooper (COO)$15.9B
West Pharmaceutical Services (WST)$14.6B
Align Technology (ALGN)$12.5B
Henry Schein (HSIC)$7.9B
Merit Medical Systems (MMSI)$5.4B
Patterson (PDCO)$2.8B
DENTSPLY SIRONA (XRAY)$2.6B
CONMED (CNMD)$1.5B
STAAR Surgical (STAA)$833M
Pro-Dex (PDEX)$198M
Lifevantage (LFVN)$169M